Sign inJoin waitlistJoin the waitlist

HF

Howard Fingert

Hematology & Oncology

Credentials: ·

Research

Safety, pharmacokinetic, and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumors
Journal of Clinical Oncology · 2012 · 215 citations
Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas
Journal of Clinical Oncology · 2014 · 187 citations
In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle
Cancer Research · 1993 · 183 citations

HB
Howard Burris
3 papers
JI
Jeffrey Infante
3 papers
Elizabeth Dees
2 papers
JB
José Baselga
2 papers
Margaret von Mehren
2 papers
OE
Omar Eton
2 papers · 2 as a fellow
RC
Roger Cohen
2 papers
WG
Walter Gajewski
2 papers · 1 as a fellow
AA
Amit Agarwal
1 paper · 1 as a fellow
AP
Amita Patnaik
1 paper
Ann Thor
1 paper
AP
Anthony Pu
1 paper